• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

May 18, 2021

Recommended Age for Colorectal Cancer Screenings Lowered from 50 to 45

Author(s):

Aislinn Antrim, Managing Editor

The incidence of colorectal cancer in adults between the ages of 40 and 49 years has increased by nearly 15% since 2000.

The United States Preventive Services Task Force announced a new recommendation today for colorectal cancer screenings, lowering the recommended age to begin screenings from 50 to 45 years of age. The task force also recommended selective screenings among adults 76 to 85 years of age based on their overall health and prior screening history.1

All adults between 45 and 75 years of age should be screened for colon and rectal cancers, according to the recommendation. This includes people of average risk who have no symptoms or prior diagnosis of colorectal cancer, as well as those with no history of colon or rectal polyps or family history of genetic disorders that put them at a higher risk for these cancers.1

Colorectal cancer is the third leading cause of cancer deaths for both men and women, according to the task force recommendation, which estimated that 52,980 people in the United States will die of colorectal cancer in 2021. Although it is most frequently diagnosed in patients 65 to 74 years of age, the recommendation said that approximately 10.5% of new cases occur in people younger than 50 years.1

Notably, the incidence of colorectal cancer in adults between 40 and 49 years of age has increased by nearly 15% since 2000. In 2016, 25.6% of eligible adults in the United States had never been screened for colorectal cancer, and in 2018, 31.2% were not up to date with screening.1 These trends are a major cause of the new recommendation, according to the task force.2

“Far too many people in the US are not receiving this lifesaving preventive service,” said task force Vice Chair Michael Barry, MD, in a press release. “We hope that this new recommendation to screen people ages 45 to 59, coupled with our long-standing recommendation to screen people 50 to 75, will prevent more people from dying from colorectal cancer.”2

The recommendation includes 2 types of screenings for colorectal cancer: direct visualization tests and stool-based tests.2

“Based on the evidence, there are many tests available that can effectively screen for colorectal cancer, and the right test is the one that gets done,” said task force member Martha Kubik, PhD, RN, in the press release. “To encourage screening and help patients select the best test for them, we urge primary care clinicians to talk about the pros and cons of the various recommended options with their patients.”2

In addition to these broad recommendations for all patients 45 years of age and older, the recommendation noted disparities among Black Americans. Between 2013 and 2017, the recommendation said there were 43.6 cases of colorectal cancer per 100,000 Black adults, compared to 37.8 cases per 100,000 White adults.1 To help address these disparities, the press release said the task force members urge clinicians to reach out to their Black patients to help make sure they are receiving regular screenings.2

REFERENCES

1. Final Recommendation Statement: Screening for Colorectal Cancer. US Preventive Services Task Force; May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Accessed May 18, 2021.

2. US Preventive Services Task Force Issues Final Recommendation on Screening for Colorectal Cancer [news release]. US Preventive Services Task Force; May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/colorectal-cancer-screening-final-rec-bulletin.pdf. Accessed May 18, 2021.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC
Related Content
Advertisement
Visualization of CAR T-cell among red blood cells | Image Credit: © Olha - stock.adobe.com
July 1st 2025

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Destruction of lymphoblasts. Conceptual 3D illustration of treatment of acute lymphoblastic leukemia - Image credit: Dr_Microbe | stock.adobe.com
July 1st 2025

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
digital representation of car t cells targeting lymphoma cells vibrant and scientific lymphoma car t cell therapy for lymphoma
June 30th 2025

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Luke Halpern, Assistant Editor
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Visualization of CAR T-cell among red blood cells | Image Credit: © Olha - stock.adobe.com
July 1st 2025

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Destruction of lymphoblasts. Conceptual 3D illustration of treatment of acute lymphoblastic leukemia - Image credit: Dr_Microbe | stock.adobe.com
July 1st 2025

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
digital representation of car t cells targeting lymphoma cells vibrant and scientific lymphoma car t cell therapy for lymphoma
June 30th 2025

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Luke Halpern, Assistant Editor
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.